Resolvyx Pharmaceuticals Obtains $17,000,000 Series A Financing

  • Feed Type
  • Date
    12/9/2005
  • Company Name
    Resolvyx Pharmaceuticals
  • Mailing Address
    6A Preston Court Bedford, MA 01730
  • Company Description
    Resolvyx is a biopharmaceutical company committed to the discovery and development of therapies based on the novel concept of inflammation resolution through activation of the body’s own off-switch mechanisms.
  • Website
    http://www.resolvyx.com/
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $17,000,000
  • Transaction Round
    Series A
  • Proceeds Purposes
    Proceeds purposes were not disclosed.
  • M&A Terms
  • Venture Investor
    Atlas Venture
  • Venture Investor
    CHL Medical Partners
  • Venture Investor
    Flagship Ventures

Trending on Xconomy